CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 217 enrolled
Drug / intervention
sleeve gastrectomy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00356213
NCT00356213N/ACompleted

Laparoscopic Sleeve Gastrectomy or Laparoscopic Proximal Roux-Y-gastric Bypass in the Treatment of Morbid Obesity

University Hospital, Basel, Switzerland·interventional·Posted Jul 25, 2006·Updated Sep 14, 2017

In Brief

A clinical study evaluating sleeve gastrectomy and Roux-Y-gastric bypass for Morbid Obesity. Completed, enrolled 217 participants.

Detailed Summary

The laparoscopic sleeve-gastrectomy (SG) compared to laparoscopic proximal Roux-Y-gastric bypass (PGB) is as successful in the treatment of morbid obesity in the majority of patients. In case of insufficient weight loss malabsorption can to be added by performing laparoscopic bilious-pancreatic diversion duodenal switch (BPD). The resection of the gastric fundus (LG) leads to changes in gastrointestinal hormones that are possibly different to bypassing the fundus (PGB).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMorbid Obesity
Countries--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 25, 2006
Enrollment StartOct 30, 2006
Primary CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 10.8 yearsPosted 19.9 years ago

Interventions

sleeve gastrectomyprocedure

laparoscopic sleeve gastrectomy

Roux-Y-gastric bypassprocedure

laparoscopic gastric bypass